Differential Impacts of Multimorbidity on COVID-19 Severity across the Socioeconomic Ladder in Hong Kong: A Syndemic Perspective.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
02 08 2021
Historique:
received: 09 06 2021
revised: 27 07 2021
accepted: 28 07 2021
entrez: 7 8 2021
pubmed: 8 8 2021
medline: 12 8 2021
Statut: epublish

Résumé

The severity of COVID-19 infections could be exacerbated by the epidemic of chronic diseases and underlying inequalities in social determinants of health. Nonetheless, there is scanty evidence in regions with a relatively well-controlled outbreak. This study examined the socioeconomic patterning of COVID-19 severity and its effect modification with multimorbidity in Hong Kong. 3074 local COVID-19 cases diagnosed from 5 July to 31 October 2020 were analyzed and followed up until 30 November 2020. Data on residential addresses, socio-demographic background, COVID-19 clinical conditions, and pre-existing chronic diseases of confirmed cases were retrieved from the Centre for Health Protection and the Hospital Authority. Results showed that, despite an independent adverse impact of multimorbidity on COVID-19 severity (aOR = 2.35 [95% CI = 1.72-3.19]), it varied across the socioeconomic ladder, with no significant risk among those living in the wealthiest areas (aOR = 0.80 [0.32-2.02]). Also, no significant association of the area-level income-poverty rate with severe COVID-19 was observed. In conclusion, the socioeconomic patterning of severe COVID-19 was mild in Hong Kong. Nonetheless, socioeconomic position interacted with multimorbidity to determine COVID-19 severity with a mitigated risk among the socioeconomically advantaged. Plausible explanations include the underlying socioeconomic inequalities in chronic disease management and the equity impact of the public-private dual-track healthcare system.

Identifiants

pubmed: 34360461
pii: ijerph18158168
doi: 10.3390/ijerph18158168
pmc: PMC8346110
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Cardiovasc Diabetol. 2020 Oct 1;19(1):164
pubmed: 33004045
J Gerontol A Biol Sci Med Sci. 2021 Feb 25;76(3):e52-e59
pubmed: 32598450
Int J Environ Res Public Health. 2020 Jul 17;17(14):
pubmed: 32709002
BMC Public Health. 2010 Jul 06;10:397
pubmed: 20602806
Clin Infect Dis. 2021 May 18;72(10):e466-e475
pubmed: 33005933
PLoS One. 2015 Oct 09;10(10):e0140040
pubmed: 26451589
Soc Sci Med. 2007 Jan;64(1):199-212
pubmed: 17014944
Med Anthropol Q. 2020 Dec;34(4):488-503
pubmed: 33274530
PLoS One. 2018 Nov 14;13(11):e0205794
pubmed: 30427845
J Med Internet Res. 2020 Jun 2;22(6):e19361
pubmed: 32452816
BMC Med. 2017 Aug 24;15(1):152
pubmed: 28835246
Scand J Public Health. 2021 Feb;49(1):104-113
pubmed: 33427079
Stud Health Technol Inform. 2001;84(Pt 1):609-13
pubmed: 11604809
Aust N Z J Public Health. 2018 Apr;42(2):186-194
pubmed: 29442409
J Epidemiol Community Health. 2020 Nov;74(11):964-968
pubmed: 32535550
J Epidemiol Community Health. 2021 Jan 5;:
pubmed: 33402396
Br J Gen Pract. 2020 Oct 29;70(700):e817-e824
pubmed: 32988955
Lancet Glob Health. 2020 Aug;8(8):e1003-e1017
pubmed: 32553130
BMC Health Serv Res. 2014 Oct 31;14:536
pubmed: 25367263
J Epidemiol Community Health. 2006 Jan;60(1):7-12
pubmed: 16361448
Rev Bras Enferm. 2020 Nov 13;73(Suppl 2):e20200673
pubmed: 33206820
BMC Public Health. 2019 Feb 21;19(1):221
pubmed: 30791882
Bioinformatics. 2014 Oct;30(19):2811-2
pubmed: 24930139
Ann Fam Med. 2018 Mar;16(2):127-131
pubmed: 29531103
Health Place. 2020 Nov;66:102465
pubmed: 33130449
BMC Med. 2021 Feb 22;19(1):51
pubmed: 33612113
Br J Anaesth. 2020 Sep;125(3):238-242
pubmed: 32731958
Int J Equity Health. 2020 Jan 28;19(1):13
pubmed: 31992307
Int J Epidemiol. 2012 Apr;41(2):514-20
pubmed: 22253321
Gut. 2021 Apr;70(4):733-742
pubmed: 32641471
JAMA Netw Open. 2021 Jul 1;4(7):e2117060
pubmed: 34259847
Diabetes Care. 2018 Jan;41(Suppl 1):S13-S27
pubmed: 29222373
J Public Health (Oxf). 2019 Sep 30;41(3):476-486
pubmed: 30215743
BMC Med Inform Decis Mak. 2020 Dec 7;20(1):323
pubmed: 33287804
J Am Soc Nephrol. 2021 Jan 22;:
pubmed: 33483314
Eur J Public Health. 2020 Oct 1;30(5):1013-1018
pubmed: 32460329
Int J Environ Res Public Health. 2020 Aug 03;17(15):
pubmed: 32756382
Aging Cell. 2020 Oct;19(10):e13237
pubmed: 32955770
J Community Health. 2021 Apr;46(2):292-297
pubmed: 32671516
J Epidemiol Community Health. 2020 Oct 24;:
pubmed: 33099506

Auteurs

Gary Ka-Ki Chung (GK)

CUHK Institute of Health Equity, The Chinese University of Hong Kong, Hong Kong SAR, China.

Siu-Ming Chan (SM)

CUHK Institute of Health Equity, The Chinese University of Hong Kong, Hong Kong SAR, China.
Department of Social and Behavioural Sciences, City University of Hong Kong, Kowloon Tong, Hong Kong SAR, China.

Yat-Hang Chan (YH)

CUHK Institute of Health Equity, The Chinese University of Hong Kong, Hong Kong SAR, China.

Terry Cheuk-Fung Yip (TC)

Department of Medicine and Therapeutics, Prince of Wales Hospital, Shatin, New Territories, Hong Kong SAR, China.
Medical Data Analytic Centre, The Chinese University of Hong Kong, Hong Kong SAR, China.
Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China.

Hon-Ming Ma (HM)

Department of Medicine and Therapeutics, Prince of Wales Hospital, Shatin, New Territories, Hong Kong SAR, China.

Grace Lai-Hung Wong (GL)

Department of Medicine and Therapeutics, Prince of Wales Hospital, Shatin, New Territories, Hong Kong SAR, China.
Medical Data Analytic Centre, The Chinese University of Hong Kong, Hong Kong SAR, China.
Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China.

Roger Yat-Nork Chung (RY)

CUHK Institute of Health Equity, The Chinese University of Hong Kong, Hong Kong SAR, China.
The Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong SAR, China.
CUHK Institute of Ageing, The Chinese University of Hong Kong, Hong Kong SAR, China.

Hung Wong (H)

CUHK Institute of Health Equity, The Chinese University of Hong Kong, Hong Kong SAR, China.
Department of Social Work, The Chinese University of Hong Kong, Hong Kong SAR, China.

Samuel Yeung-Shan Wong (SY)

CUHK Institute of Health Equity, The Chinese University of Hong Kong, Hong Kong SAR, China.
The Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong SAR, China.

Eng Kiong Yeoh (EK)

CUHK Institute of Health Equity, The Chinese University of Hong Kong, Hong Kong SAR, China.
The Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong SAR, China.

Michael Marmot (M)

CUHK Institute of Health Equity, The Chinese University of Hong Kong, Hong Kong SAR, China.
UCL Institute of Health Equity, UCL Research Department of Epidemiology and Public Health, University College London, London WC1E 6BT, UK.

Jean Woo (J)

CUHK Institute of Health Equity, The Chinese University of Hong Kong, Hong Kong SAR, China.
Department of Medicine and Therapeutics, Prince of Wales Hospital, Shatin, New Territories, Hong Kong SAR, China.
CUHK Institute of Ageing, The Chinese University of Hong Kong, Hong Kong SAR, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH